{"id":"NCT01369212","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","briefTitle":"Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B","officialTitle":"Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2021-03-08","completion":"2021-03-08","firstPosted":"2011-06-08","resultsPosted":"2022-10-12","lastUpdate":"2023-04-28"},"enrollment":201,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis B"],"interventions":[{"type":"DRUG","name":"Tenofovir","otherNames":["Hepatitis B","Viread"]},{"type":"DRUG","name":"Peginterferon-alfa 2a and tenofovir","otherNames":["Hepatitis B","PEGASYS","Viread","tenofovir"]}],"arms":[{"label":"Tenofovir","type":"EXPERIMENTAL"},{"label":"Peginterferon-alfa 2a and tenofovir","type":"EXPERIMENTAL"}],"summary":"This clinical trial compares the efficacy of peginterferon plus tenofovir for 24 weeks followed by monotherapy with tenofovir for a further 3.5 years to the efficacy of tenofovir alone given for 4 years in patients with chronic hepatitis B. The primary measure of outcome will be HBsAg loss in serum at 48 weeks after stopping all antiviral therapy (sustained off-treatment response).","primaryOutcome":{"measure":"Percent of Participants With Hepatitis B Surface Antigen (HBsAg) Loss by Week 240","timeFrame":"Week 240","effectByArm":[{"arm":"Tenofovir","deltaMin":4.1,"sd":null},{"arm":"Peginterferon-alfa 2a and Tenofovir","deltaMin":5.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.72"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":20},"locations":{"siteCount":21,"countries":["United States","Canada"]},"refs":{"pmids":["39478672","36728214","36599136"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":102},"commonTop":["RASH","BACK PAIN","DEPRESSION","URINARY TRACT INFECTION","WEIGHT LOSS"]}}